The right diagnosis,
right away,
at the right price.

We are the creators of Genomtec ID, a mobile platform for genetic diagnostics at the point of patient care. We have just obtained our CE-IVD Mark for the GenomtecID Respiratory Panel 5-Plex (RP5-PLEX) which detects viruses and bacteria causing respiratory tract infections, the only solution of this kind in Europe. See more >>



Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

Genomtec S.A., announces that the Extraordinary General Meeting of Shareholders of the company appointed Dr. Trevor Hawkins to the Supervisory Board as of April 22, 2024. Miron Tokarski, co-founder, shareholder, and CEO of Genomtec, comments: “We are very pleased that Dr. Trevor Hawkins – a seasoned leader in business development, R&D, and commercial operations at […]


Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project – Company will raise capital from founding shareholders and investors

Genomtec will raise PLN 10.6 million (equivalent to over USD 2.6 million), most of which will be used to fund the research & development of its first oncology project “OncoSNAAT” – key to the company’s value growth. Genomtec has entered into an investment agreement with ten shareholders of the Company, including 5HT Family Foundation, the […]


Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Genomtec S.A.,  announces that the Extraordinary General Meeting of Shareholders of the company has appointed two new members to the Supervisory Board of the company, effective March 12th, 2024: Gualtiero Garlasco and Beata Turlejska, who will replace Jarosław Oleszczuk and Karol Hop. Both Mr. Gualtiero Garlasco and Ms. Beata Turlejska will also serve as members […]